Diadema Partners’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,000
Closed -$804K 63
2025
Q1
$804K Buy
+20,000
New +$804K 0.21% 31